Feb 6, 2024
Bivalent mRNA COVID-19 vaccines were recommended for children
and adolescents aged 5 to 17 years in the US, but were they
effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with
author Leora R. Feldstein, PhD, US Centers for Disease Control and
Prevention, about the effectiveness of bivalent COVID-19 vaccines
in children and adolescents.
Related Content: